ArticleRadiation oncology (London, England)2022

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma.

Jing Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.